311340-72-4

Upstream product

• 88-65-3 2-bromobenzoic-acid 
• 7154-66-7 2-bromobenzoic acid chloride 
• 50671-05-1 3-(2-bromophenyl)-3-oxopropionic acid ethyl ester 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 

Downstream Products

• 1332622-31-7 ethyl 3-(2-bromophenyl)-2-[(4-pyridinmethylamino)methylene]-3-oxopropanoate 
• 1332622-34-0 ethyl 4-oxo-1-(1-methyl-3-phenylpropyl)-1,4-dihydroquinoline-3-carboxylate 
• 1332622-38-4 4-oxo-1-(1-methyl-3-phenylpropyl)-1,4-dihydroquinoline-3-carboxylic acid 
• 1332622-47-5 4-oxo-1-(1-methyl-3-phenylpropyl)-N-(1-phenylethyl)-1,4-dihydroquinoline-3-carboxamide 
• 1332622-48-6 4-oxo-1-(1-methyl-3-phenylpropyl)-N-(2-methylphenyl)-1,4-dihydroquinoline-3-carboxamide 
• 1332622-30-6 ethyl 3-(2-bromophenyl)-2-[(4-phenylbutyl-2-amino)methylene]-3-oxopropanoate 

Relevant academic research and scientific papers

An expeditious synthesis of some novel n-pyridyl-1,4-dihydro-4-oxo-3- quinoline carboxylic acids/amides as potential CB2 cannabinoid receptor agonists

An expeditious synthesis of novel N-pyridyl-1,4-dihydro-4-oxo-3-quinoline carboxylic acids (9a-e) in 5 steps and N-pyridyl-4-oxo-1,4-dihydroquinoline-3- carboxamides (1a-m) were developed in six steps from a commercially available 2-bromo benzoic acid.